<VariationArchive VariationID="5290" VariationName="NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del)" VariationType="Deletion" Accession="VCV000005290" Version="31" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="13" DateLastUpdated="2024-04-06" DateCreated="2016-06-09" MostRecentSubmission="2024-04-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20329" VariationID="5290">
      <GeneList>
        <Gene Symbol="TBCE" FullName="tubulin folding cofactor E" GeneID="6905" HGNC_ID="HGNC:11582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235367427" stop="235452443" display_start="235367427" display_stop="235452443" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_014040927.1" start="7228" stop="96035" display_start="7228" display_stop="96035" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235530727" stop="235612279" display_start="235530727" display_stop="235612279" Strand="+" />
          </Location>
          <OMIM>604934</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del)</Name>
      <CanonicalSPDI>NC_000001.11:235401552:GGGAGCCACGAAGGGA:GGGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235401553" stop="235401564" display_start="235401553" display_stop="235401564" variantLength="12" positionVCF="235401552" referenceAlleleVCF="TGGGAGCCACGAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235564868" stop="235564879" display_start="235564868" display_stop="235564879" variantLength="12" positionVCF="235564867" referenceAlleleVCF="TGGGAGCCACGAA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.235564872_235564883del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.235564872_235564883del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.235401557_235401568del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.235401557_235401568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009230.1" sequenceAccession="NG_009230" sequenceVersion="1" change="g.39145_39156del">
            <Expression>NG_009230.1:g.39145_39156del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079515.3" sequenceAccession="NM_001079515" sequenceVersion="3" change="c.155_166del">
            <Expression>NM_001079515.3:c.155_166del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001072983.1" sequenceAccession="NP_001072983" sequenceVersion="1" change="p.Ser52_Gly55del">
            <Expression>NP_001072983.1:p.Ser52_Gly55del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287801.2" sequenceAccession="NM_001287801" sequenceVersion="2" change="c.155_166del">
            <Expression>NM_001287801.2:c.155_166del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274730.1" sequenceAccession="NP_001274730" sequenceVersion="1" change="p.Ser52_Gly55del">
            <Expression>NP_001274730.1:p.Ser52_Gly55del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003193.5" sequenceAccession="NM_003193" sequenceVersion="5" change="c.155_166del" MANESelect="true">
            <Expression>NM_003193.5:c.155_166del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003184.1" sequenceAccession="NP_003184" sequenceVersion="1" change="p.Ser52_Gly55del">
            <Expression>NP_003184.1:p.Ser52_Gly55del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287802.2" sequenceAccession="NM_001287802" sequenceVersion="2" change="c.-210-12876_-210-12865del">
            <Expression>NM_001287802.2:c.-210-12876_-210-12865del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003193.4" sequenceAccession="NM_003193" sequenceVersion="4" change="c.155_166delGCCACGAAGGGA">
            <Expression>NM_003193.4:c.155_166delGCCACGAAGGGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212825" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604934.0001" DB="OMIM" />
        <XRef Type="rs" ID="767004810" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 12389028 Fig. 2a to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del) AND Hypoparathyroidism-retardation-dysmorphism syndrome" Accession="RCV000005608" Version="12">
        <ClassifiedConditionList TraitSetID="1471">
          <ClassifiedCondition DB="MedGen" ID="C1855840">Hypoparathyroidism-retardation-dysmorphism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-22" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del) AND Autosomal recessive Kenny-Caffey syndrome" Accession="RCV000191990" Version="7">
        <ClassifiedConditionList TraitSetID="6463">
          <ClassifiedCondition DB="MedGen" ID="C1855648">Autosomal recessive Kenny-Caffey syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del) AND not provided" Accession="RCV000224858" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-13" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003193.5(TBCE):c.155_166del (p.Ser52_Gly55del) AND Encephalopathy, progressive, with amyotrophy and optic atrophy" Accession="RCV003989279" Version="1">
        <ClassifiedConditionList TraitSetID="33802">
          <ClassifiedCondition DB="MedGen" ID="C4310667">Encephalopathy, progressive, with amyotrophy and optic atrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="14" NumberOfSubmitters="13" DateCreated="2016-06-09" MostRecentSubmission="2024-04-06">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12389028</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20152369</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25097779</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26231322</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26336027</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30080992</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30638765</ID>
        </Citation>
        <DescriptionHistory Dated="2018-07-06">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33802" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36343" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, progressive, with amyotrophy and optic atrophy</ElementValue>
                <XRef ID="MONDO:0014968" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PEAMO</ElementValue>
                <XRef Type="MIM" ID="617207" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310667" DB="MedGen" />
              <XRef ID="MONDO:0014968" DB="MONDO" />
              <XRef Type="MIM" ID="617207" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6463" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5356" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Kenny-Caffey syndrome</ElementValue>
                <XRef ID="MONDO:0009486" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kenny-Caffey syndrome type 1</ElementValue>
                <XRef ID="Kenny-Caffey+syndrome+type+1/3969" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KCS1</ElementValue>
                <XRef Type="MIM" ID="244460" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8367" />
                <XRef ID="8367" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2333" DB="Orphanet" />
              <XRef ID="93324" DB="Orphanet" />
              <XRef ID="C1855648" DB="MedGen" />
              <XRef ID="MONDO:0009486" DB="MONDO" />
              <XRef Type="MIM" ID="244460" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1471" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sanjad-Sakati syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HRD syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypoparathyroidism with short stature, mental retardation and seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypoparathyroidism, congenital, associated with dysmorphism, growth retardation and developmental delay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypoparathyroidism-retardation-dysmorphism syndrome</ElementValue>
                <XRef ID="MONDO:0009426" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HRDS</ElementValue>
                <XRef Type="MIM" ID="241410" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HRD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="411" />
                <XRef ID="411" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2323" DB="Orphanet" />
              <XRef ID="C1855840" DB="MedGen" />
              <XRef ID="MONDO:0009426" DB="MONDO" />
              <XRef Type="MIM" ID="241410" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1521481" SubmissionDate="2018-06-12" DateLastUpdated="2017-01-06" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="RaPS_21|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000778576" DateUpdated="2017-01-06" DateCreated="2017-01-06" Type="SCV" Version="1" SubmitterName="Centre for Translational Omics - GOSgene, University College London" OrgID="505378" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079515.2:c.155_166delGCCACGAAGGGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4143604</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3978192" SubmissionDate="2021-11-29" DateLastUpdated="2021-12-04" DateCreated="2021-12-04">
        <ClinVarSubmissionID localKey="NM_001287801.1:c.155_166del|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002028329" DateUpdated="2021-12-04" DateCreated="2021-12-04" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001287801.1:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10730449</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4940930" SubmissionDate="2022-05-28" DateLastUpdated="2022-06-03" DateCreated="2022-06-03">
        <ClinVarSubmissionID localKey="1-235564867-TGGGAGCCACGAA-T" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002521836" DateUpdated="2022-06-03" DateCreated="2022-06-03" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30638765</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26231322</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20152369</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25097779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12389028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30080992</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26336027</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Inframe deletion located in a nonrepeat region: predicted to change the length of the protein and disrupt normal protein function. Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID:12389028). The variant has been observed in multiple (&gt;3) similarly affected unrelated individuals (PMID:12389028, 20152369, 25097779, 26231322, 26336027, 30080992, 30638765). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000829" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001525" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002199" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002901" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.5:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11507599</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7342194" SubmissionDate="2023-05-30" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="NM_001287801.1:c.155_166del|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003927852" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)" OrgID="508930" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001287801.1:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13483232</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25790" SubmissionDate="2016-11-29" DateLastUpdated="2023-07-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604934.0001_HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME" title="TBCE, 12-BP DEL, NT155_HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME" />
        <ClinVarAccession Accession="SCV000025790" DateUpdated="2023-07-22" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Parvari et al. (2002) demonstrated homozygosity for a 12-bp deletion in the second coding exon of the TBCE gene in all Middle Eastern individuals with hypoparathyroidism-retardation-dysmorphism syndrome (HRDS; 241410) whom they evaluated (more than 50). The deletion was not present in more than 350 control chromosomes from Arab individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">12389028</ID>
              </Citation>
              <XRef DB="OMIM" ID="241410" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">All the Middle Eastern subjects studied by Parvari et al. (2002) had the 12-bp deletion in the TBCE gene; however, the phenotype in 8 pedigrees with 13 affected individuals was that of autosomal recessive Kenny-Caffey syndrome (KCS1; 244460), differing from the phenotype in HRDS families (17 Saudi pedigrees, 27 affected individuals; 9 Israeli pedigrees, 25 affected individuals) owing to the additional presence of medullary stenosis of the long bones, calvarial osteosclerosis, and susceptibility to bacterial infection. The presence of patchy osteosclerosis in the long bones of some Saudi patients with HRDS and deaths secondary to sepsis in some Israeli Bedouin individuals with HRDS suggested variable expression of these phenotypic features in a pedigree-specific fashion.</Attribute>
              <Citation>
                <ID Source="PubMed">12389028</ID>
              </Citation>
              <XRef DB="OMIM" ID="244460" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a female infant, born of consanguineous Moroccan parents, with HRDS, Ratbi et al. (2015) identified homozygosity for the 12-bp deletion (c.155_166del12) that was previously found only in patients of Middle Eastern descent. The findings were consistent with the history of Arab migration to Morocco with the expansion of Islam to North Africa in the 7th century.</Attribute>
              <Citation>
                <ID Source="PubMed">26336027</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <Name>TBCE, 12-BP DEL, NT155</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">12-BP DEL, NT155</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604934.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="457836" SubmissionDate="2016-11-29" DateLastUpdated="2023-07-22" DateCreated="2015-10-01">
        <ClinVarSubmissionID localKey="604934.0001_KENNY-CAFFEY SYNDROME, TYPE 1" title="TBCE, 12-BP DEL, NT155_KENNY-CAFFEY SYNDROME, TYPE 1" />
        <ClinVarAccession Accession="SCV000246253" DateUpdated="2023-07-22" DateCreated="2015-10-01" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Parvari et al. (2002) demonstrated homozygosity for a 12-bp deletion in the second coding exon of the TBCE gene in all Middle Eastern individuals with hypoparathyroidism-retardation-dysmorphism syndrome (HRDS; 241410) whom they evaluated (more than 50). The deletion was not present in more than 350 control chromosomes from Arab individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">12389028</ID>
              </Citation>
              <XRef DB="OMIM" ID="241410" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">All the Middle Eastern subjects studied by Parvari et al. (2002) had the 12-bp deletion in the TBCE gene; however, the phenotype in 8 pedigrees with 13 affected individuals was that of autosomal recessive Kenny-Caffey syndrome (KCS1; 244460), differing from the phenotype in HRDS families (17 Saudi pedigrees, 27 affected individuals; 9 Israeli pedigrees, 25 affected individuals) owing to the additional presence of medullary stenosis of the long bones, calvarial osteosclerosis, and susceptibility to bacterial infection. The presence of patchy osteosclerosis in the long bones of some Saudi patients with HRDS and deaths secondary to sepsis in some Israeli Bedouin individuals with HRDS suggested variable expression of these phenotypic features in a pedigree-specific fashion.</Attribute>
              <Citation>
                <ID Source="PubMed">12389028</ID>
              </Citation>
              <XRef DB="OMIM" ID="244460" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a female infant, born of consanguineous Moroccan parents, with HRDS, Ratbi et al. (2015) identified homozygosity for the 12-bp deletion (c.155_166del12) that was previously found only in patients of Middle Eastern descent. The findings were consistent with the history of Arab migration to Morocco with the expansion of Islam to North Africa in the 7th century.</Attribute>
              <Citation>
                <ID Source="PubMed">26336027</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <Name>TBCE, 12-BP DEL, NT155</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">12-BP DEL, NT155</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604934.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">KENNY-CAFFEY SYNDROME, TYPE 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963158" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="3801712ac8ab39683587e0ecb09b0fc4df46bc61677fd623b1ed9a0973c36caa|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002018933" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.5:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6213631" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4825482|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524137" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12389028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20152369</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26231322</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30080992</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12389028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30080992</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 5290). This variant has been observed in individuals with hypoparathyroidism-retardation-dysmorphism syndrome (PMID: 12389028, 20152369, 26231322, 30080992). It is commonly reported in individuals of Middle Eastern ancestry (PMID: 12389028, 30080992). This variant is present in population databases (rs767004810, gnomAD 0.006%). This variant, c.155_166del, results in the deletion of 4 amino acid(s) of the TBCE protein (p.Ser52_Gly55del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.235564868_235564879del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="529983" SubmissionDate="2016-05-19" DateLastUpdated="2016-06-09" DateCreated="2016-06-09">
        <ClinVarSubmissionID localKey="108103614" />
        <ClinVarAccession Accession="SCV000280889" DateUpdated="2016-06-09" DateCreated="2016-06-09" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.000224</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" Strand="+" alternateAllele="-" referenceAllele="GGGAGCCACGAA" start="235564868" stop="235564879" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1747481" SubmissionDate="2018-10-25" DateLastUpdated="2017-01-06" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="NM_003193.4:c.155_166del|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000891681" DateUpdated="2017-01-06" DateCreated="2017-01-06" Type="SCV" Version="1" SubmitterName="Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University" OrgID="506653" OrganizationCategory="laboratory" OrgAbbreviation="SQUH-Genetics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25097779</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.4:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4684823</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1954595" SubmissionDate="2019-06-18" DateLastUpdated="2019-10-19" DateCreated="2019-10-19">
        <ClinVarSubmissionID localKey="NM_003193.4:c.155_166delGCCACGAAGGGA|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000996294" DateUpdated="2019-10-19" DateCreated="2019-10-19" Type="SCV" Version="1" SubmitterName="Pathology and Clinical Laboratory Medicine, King Fahad Medical City" OrgID="506801" OrganizationCategory="laboratory" OrgAbbreviation="KFMC" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Arab</Ethnicity>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="10" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.4:c.155_166delGCCACGAAGGGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5841897</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2348937" SubmissionDate="2020-02-12" DateLastUpdated="2020-03-29" DateCreated="2020-03-29">
        <ClinVarSubmissionID localKey="NM_003193.4:c.155_166del|OMIM:241410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001190740" DateUpdated="2020-03-29" DateCreated="2020-03-29" Type="SCV" Version="1" SubmitterName="Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City" OrgID="506517" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.4:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6959288</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3558299" SubmissionDate="2021-09-01" DateLastUpdated="2021-09-08" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="GDXSV:56205" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001820079" DateUpdated="2021-09-08" DateCreated="2021-09-08" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>In-frame deletion of 4 amino acids in a non-repeat region; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31589614, 26231322, 30638765, 30049826, 25097779, 12389028, 26336027, 20152369, 30080992, 29620724)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBCE" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1749730</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003193.4:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_28_20210831083931</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8986322" SubmissionDate="2024-03-25" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_001079515.3:c.155_166del|OMIM:617207" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004805967" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079515.3:c.155_166del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617207" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14337453</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3963158" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000829" MappingRef="HP">
        <MedGen CUI="C0020626" Name="Hypoparathyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1954595" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7342194" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002199" MappingRef="HP">
        <MedGen CUI="C1855841" Name="Hypocalcemic seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6213631" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8986322" TraitType="Disease" MappingType="XRef" MappingValue="617207" MappingRef="OMIM">
        <MedGen CUI="C4310667" Name="Encephalopathy, progressive, with amyotrophy and optic atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940930" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001525" MappingRef="HP">
        <MedGen CUI="C1855514" Name="Severe failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1521481" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002901" MappingRef="HP">
        <MedGen CUI="C0020598" Name="Hypocalcemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3558299" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="529983" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="457836" TraitType="Disease" MappingType="Name" MappingValue="KENNY-CAFFEY SYNDROME, TYPE 1" MappingRef="Alternate">
        <MedGen CUI="C1855648" Name="Autosomal recessive Kenny-Caffey syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3978192" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2348937" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747481" TraitType="Disease" MappingType="XRef" MappingValue="241410" MappingRef="OMIM">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25790" TraitType="Disease" MappingType="Name" MappingValue="HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1855840" Name="Hypoparathyroidism-retardation-dysmorphism syndrome" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2015-09-30">SCV000025791</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

